Page last updated: 2024-08-24

1,2-distearoyllecithin and Carcinoma, Anaplastic

1,2-distearoyllecithin has been researched along with Carcinoma, Anaplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwatsuru, M; Koyama, M; Maruyama, K; Suginaka, A; Takahashi, N; Unezaki, S; Yuda, T1
Ishida, O; Iwatsuru, M; Maruyama, K; Takahashi, N; Unezaki, S1

Other Studies

2 other study(ies) available for 1,2-distearoyllecithin and Carcinoma, Anaplastic

ArticleYear
Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
    Pharmaceutical research, 1994, Volume: 11, Issue:8

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Carcinoma; Colonic Neoplasms; Doxorubicin; Hydrogen-Ion Concentration; Hyperthermia, Induced; Liposomes; Male; Mice; Mice, Inbred BALB C; Molecular Weight; Phosphatidylcholines; Polyethylene Glycols; Tissue Distribution

1994
Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
    Journal of drug targeting, 1993, Volume: 1, Issue:4

    Topics: Animals; Carcinoma; Cholesterol; Colonic Neoplasms; Doxorubicin; Drug Carriers; Drug Compounding; G(M1) Ganglioside; Hydrogen-Ion Concentration; Liposomes; Male; Mice; Mice, Inbred BALB C; Particle Size; Phosphatidylcholines; Tissue Distribution

1993